BRCA2 and uterine cancer: A cohort study that included 2609 women found no increase vs. the expected risk in the general population [68], but a subsequent meta-analysis found that the BRCA1/BRCA2 mutations increased the risk of any uterine cancers by 2.2 times and increased the risk of serous endometrial neoplasms by about 18 times [69].